Differential output of the high-sensitivity rod photoreceptor: AII amacrine pathway

In the mammalian retina, the scotopic threshold of ganglion cells is in part dependent on how rod inputs are summed by their presynaptic cone bipolar cells. For ON cone bipolar cells, there are two anatomical routes for rod signals: 1) cone photoreceptors receive inputs via gap junctions with the surrounding, more numerous rods; and 2) ON cone bipolar cells receive highly convergent input via gap junctions with AII amacrine cells, which each receive input from hundreds of rods. Rod-cone coupling is thought to be utilized at higher photon fluxes relative to the AII-ON cone bipolar pathway due to the impedance mismatch of a single small rod driving a larger cone. Furthermore, it is widely held that the convergence of high-gain chemical synapses onto AIIs confers the highest sensitivity to ON cone bipolar cells and ganglion cells. A lack of coupling between one or more types of ON cone bipolar cells and AIIs would obviate this high-sensitivity pathway and explain the existence of ganglion cells with elevated scotopic thresholds. To investigate this possibility, we examined Neurobiotin and glycine diffusion from AIIs to bipolar cells and found that approximately one-fifth of ON cone bipolar cells are not coupled to AIIs. Unlike AII-AII coupling, which changes with ambient background intensity, the fraction of noncoupled ON cone bipolar cells was unaltered by dark or light adaptation. These data suggest that one of five morphologically distinct ON cone bipolar cell types is not coupled to AIIs and suggest that AII-ON cone bipolar coupling is modulated differently from AII-AII coupling.     

microRNAs exhibit high frequency genomic alterations in human cancer

MicroRNAs (miRNAs) are endogenous noncoding RNAs, which negatively regulate gene expression. To determine genomewide miRNA DNA copy number abnormalities in cancer, 283 known human miRNA genes were analyzed by high-resolution array-based comparative genomic hybridization in 227 human ovarian cancer, breast cancer, and melanoma specimens. A high proportion of genomic loci containing miRNA genes exhibited DNA copy number alterations in ovarian cancer (37.1%), breast cancer (72.8%), and melanoma (85.9%), where copy number alterations observed in >15% tumors were considered significant for each miRNA gene. We identified 41 miRNA genes with gene copy number changes that were shared among the three cancer types (26 with gains and 15 with losses) as well as miRNA genes with copy number changes that were unique to each tumor type. Importantly, we show that miRNA copy changes correlate with miRNA expression. Finally, we identified high frequency copy number abnormalities of Dicer1, Argonaute2, and other miRNA-associated genes in breast and ovarian cancer as well as melanoma. These findings support the notion that copy number alterations of miRNAs and their regulatory genes are highly prevalent in cancer and may account partly for the frequent miRNA gene deregulation reported in several tumor types.     

Abnormal fertilization in ICSI and its association with abnormal semen parameters:a retrospective observational study on 1855 cases

Intracytoplasmic sperm injection(ICSI)efficiently addresses male factor infertility.However,the occurrence of abnormal fertilization,mainly characterized by abn...